First-in-human, single ascending dose study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of piromelatine [Neu-P11] in healthy male volunteers
Latest Information Update: 21 Feb 2013
At a glance
- Drugs Piromelatine (Primary)
- Indications Insomnia
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 21 Feb 2013 New trial record